Job Watch
CK Group: Senior Bioinformatician
£0 - £50000 per annum:
CK Group:
Natasha Young is recruiting for a Senior Bioinformatician to join a small, dedicated team providing an outsourced service to one of the top ten largest...
Bracknell
Categories: Job Watch
CK Group: Senior Computational Biologist
£0 - £50000 per annum:
CK Group:
Natasha Young is recruiting for a Senior Computational Biologist to join a small, dedicated team providing an outsourced service to one of the top ten...
Bracknell
Categories: Job Watch
Notice of Application Submission and Due Date Changes for RFA-HL-23-010, "Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)"
Notice NOT-HL-22-015 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NICHD Participation in PAR-22-000 "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)"
Notice NOT-HD-22-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Reproductive Scientist Development Program (RSDP) (K12 Clinical Trial Not Allowed)
Notice NOT-HD-22-006 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Application Due Date Changes for RFA-HL-23-014, "Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33)"
Notice NOT-HL-22-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Application Due Date Changes for RFA-HL-23-012, "Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)"
Notice NOT-HL-22-017 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Application Due Date Changes for RFA-HL-23-013, "Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)"
Notice NOT-HL-22-018 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Pre-Application Webinar for NOT-CA-22-056, Administrative Supplements to Support Germline Genome-wide Genotyping and Sequencing of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
Notice NOT-CA-22-064 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Termination of RFA-DA-22-033, "Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)"
Notice NOT-DA-22-059 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
Funding Opportunity RFA-CA-22-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for innovative informatics methods and algorithms to improve the acquisition, analysis, visualization, or interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, the emphasis of this FOA is on supporting the development of novel informatics capabilities that involve a high degree of innovation that have the potential to accelerate or enhance research. To be successful, there must be a clear rationale for how the proposed informatics method or algorithm is novel and how it will benefit the cancer research field. Projects proposing the application of existing methods or algorithms where the novelty resides in the biological or clinical question being pursued are not responsive to this solicitation and will not be reviewed.
Categories: Job Watch, Literature Watch
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-22-022 from the NIH Guide for Grants and Contracts. The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research projects must focus on recapitulation of the human immune system in their proposed cancer model using human cells or tissues to regenerate and/or recapitulate the human immune system in in vivo or in vitro immuno-oncology models in a manner that matches or exceeds representation of the human immune system achieved with murine models developed using HFT. Models derived from genetically manipulated immune systems without introduction of human immune lineage cells will not be considered responsive.The FOA will utilize the R33 Exploratory/Developmental Grants Phase II research activity code.
Categories: Job Watch, Literature Watch
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-22-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included. Potential applicants who are interested in early-stage development or informatics resource sustainment should consult the companion FOAs listed above.
Categories: Job Watch, Literature Watch
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
Funding Opportunity RFA-CA-22-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research resources to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources. This is in contrast to early-stage and advanced development efforts to generate these tools and resources that are supported by companion ITCR FOAs. To be successful, the proposed sustainment plan must provide clear justification for why the research resource should be maintained and how it has benefitted and will continue to benefit the cancer research field. In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting collaboration and deep engagement between the resource and the targeted research community should be described.
Categories: Job Watch, Literature Watch
Notice of Application Due Date Changes for RFA-HL-23-011,"Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)"
Notice NOT-HL-22-016 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest(NOSI): Recruitment Innovation Center (RIC) Topic Area for Limited Competition: Clinical and Translational Science Award Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
Notice NOT-TR-22-020 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI) Trial Innovation Center (TIC) Topic Area for Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)
Notice NOT-TR-22-021 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research
Notice NOT-CA-22-057 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Rothamsted Research: Senior Research Scientist - Molecular Agroecologist for Next Generation IPM
£37,890 to £41,438 per annum:
Rothamsted Research:
Ecological approaches to insect pest management (IPM) in arable systems are urgently needed to reduce insecticide use and achieve ‘green’ sustainab...
Harpenden, Hertfordshire (GB)
Categories: Job Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Impact of the Microbiome Gut-Brain Axis on ADRD (R01 Clinical Trial Not Allowed)
Notice NOT-NS-22-088 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Pages
